Hospira at outperform by Bear Stearns

Bear Stearns analyst Rick Wise rated Hospira, Inc. at outperform with a $45 price target. The company reported third-quarter earnings per share of $0.45 (+1%), in line with consensus and 5 cents above the analyst's estimate. Management lowered its 2006 sales guidance to $2.65 billion to $2.68 billion, from $2.71 billion to $2.76 billion, and reiterated 2006 earnings per share guidance of $1.97 to $2.02. Shares of the Lake Forest, Ill., specialty pharmaceutical company were down $1.32, or 3.96%, at $31.98. (NYSE: HSP)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.